Digital Stepped-Care for Depression

This trial tests a new digital approach to treating depression by comparing three methods: a self-help app called Moodivate (Behavioral Activation Therapy App), telehealth sessions with a counselor, and a combination of both. The trial aims to assess the ease of adherence to these treatments and their effectiveness in improving mood. Individuals with long-standing depression symptoms who use a smartphone may be suitable candidates, particularly if they are open to apps and online therapy. Conducted in South Carolina, this study helps researchers identify better ways to support people with depression. As an unphased trial, it offers a unique opportunity to explore innovative treatments for depression and contribute to advancing mental health care.

Research has shown that both treatments in this trial are safe. The Moodivate app, tested in several studies, greatly improves depression symptoms without serious side effects. Users track their mood and activities with the app, aiding in depression management.

For the telehealth-delivered Behavioral Activation, studies have demonstrated its safety and positive reception. Participants reported high satisfaction, and it effectively reduces depression symptoms. These studies have identified no major safety issues.

Researchers are excited about these treatments for depression because they incorporate digital tools that enhance access and flexibility. Unlike traditional face-to-face therapy, the Moodivate app allows users to engage in Behavioral Activation therapy on their phones, enabling daily self-guided activities that help improve mood. The Digitally-Enhanced Stepped Care approach takes this a step further by passively monitoring app engagement to decide if more intensive standard care is needed, offering a tailored treatment pathway. Meanwhile, the Telebehavioral Health option delivers therapy sessions via telehealth, providing the benefits of direct interaction with a therapist without the need for in-person visits. These digital approaches offer promising alternatives that could make managing depression more accessible and personalized.

Studies have shown that Behavioral Activation therapy, such as the Moodivate app, effectively reduces depression symptoms. Users of the app were three times more likely to experience meaningful improvements in their depression. One study found that participants had significant reductions in their depression scores after using the app. In this trial, participants may use the Moodivate app alone or as part of a Digitally-Enhanced Stepped Care approach. Research has also shown that Behavioral Activation therapy delivered through telehealth effectively reduces depression symptoms, with patients experiencing fewer symptoms after several sessions. Participants in this trial may also receive Behavioral Activation therapy through telehealth. Both the app and telehealth methods offer promising ways to manage depression effectively.¹²³⁵⁶